Morton Alexander, PhD

Co-Founder
Utility Therapeutics, United Kingdom

Disclosure(s): SNIPR biome: Shareholder, Stocks/Bonds (Private Company); Union therapeutics: Shareholder, Stocks/Bonds (Private Company); Utility therapeutics: Board Member, Ownership Interest

Poster(s):

• (P-1092) Re-analysis of Pivmecillinam Randomized Clinical Trial Data According to 2019 US Food and Drug Administration Guidance for the Treatment of Uncomplicated Urinary Tract Infection
  Friday, October 18, 2024

  12:15 PM – 1:30 PM US PT